Singapore

Bangkok Hospital Pattaya was awarded with three prestige Healthcare Asia Awards at the recently concluded competition acknowledging the hospital’s excellence in patient care.

The hospital's knee radiography device reduces need for patients to repeat procedure.

Patients will now enjoy services from its PCF and tele-customer care units.

The Company’s continuous investment in cutting edge technology has made it a leading diagnostics imaging provider in Asia Pacific.

Over 140 attendees flocked to the second awarding.

This outpaces STI's 12M yield of 4%.

This outpaces the benchmark STI's 12M yield of 4%.

This outpaces the benchmark STI's 12M yield of 4%.

This outpaces the benchmark STI's 12M yield of 4%.

The proceeds will be used to enhance its AI digital therapeutics platform.

Malaysia offers more competitive surgery costs with a heart bypass costing just US$14,000 compared to US$23,000 in Singapore.

It will provide SMS-based digital adherence programs in Malaysia and the Philippines.

The sector’s market cap ballooned thirteen-fold and stands at over $40b.

Select startups will get access to tech development services and seed funding.

They will cross-refer their pools of healthcare professionals to one another’s customers.

Many speak of the “war” for talent arising across the globe, including in the Asia Pacific and as it pertains to the Life Sciences industry. Whilst indeed there is a level of scarcity in certain roles and regions (though arguably public healthcare provision is much more in need than the private sector), the battle-like mentality does not take full advantage of the broader industry shift toward collaborations and alliances. According to KPMG 2018 Global CEO Survey, 61% of Life Sciences CEOs intend to work in consortia models going forward (compared to a 49% cross-industry average).